231 related articles for article (PubMed ID: 36618405)
1. Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma.
Luo L; Zhang XY; Zhen YW; Guo GC; Peng DZ; Wei C; Pei DL; Yu B; Ji YC; Liu XZ; Han L; Zhang ZY
Front Immunol; 2022; 13():1058036. PubMed ID: 36618405
[TBL] [Abstract][Full Text] [Related]
2. PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas.
Zhang X; Li Z; Wei C; Luo L; Li S; Zhou J; Liang H; Li Y; Han L
Front Oncol; 2022; 12():1055371. PubMed ID: 36620611
[TBL] [Abstract][Full Text] [Related]
3.
Ma W; Zhang K; Bao Z; Jiang T; Zhang Y
Front Immunol; 2021; 12():659659. PubMed ID: 33936093
[TBL] [Abstract][Full Text] [Related]
4. Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status.
Zhou F; Shi Q; Fan X; Yu R; Wu Z; Wang B; Tian W; Yu T; Pan M; You Y; Wang Y
Front Immunol; 2022; 13():841404. PubMed ID: 35265085
[TBL] [Abstract][Full Text] [Related]
5. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
7. IQGAP3 promotes the progression of glioma as an immune and prognostic marker.
Gao X; Ge J; Gao X; Mei NA; Su Y; Shan S; Qian W; Guan J; Zhang Z; Wang L
Oncol Res; 2024; 32(4):659-678. PubMed ID: 38560572
[No Abstract] [Full Text] [Related]
8. Extract of Astragali Radix and Solanum nigrum Linne regulates microglia and macrophage polarization and inhibits the growth and infiltration of C6 glioblastoma.
Shen M; Liu S; Wei Q; Zhang X; Wen S; Qiu R; Li Y; Fan H
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117067. PubMed ID: 37619857
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma.
Qian Y; Li Y; Chen K; Liu N; Hong X; Wu D; Xu Z; Zhou L; Xu L; Jia R; Ge YZ
J Inflamm Res; 2022; 15():1099-1116. PubMed ID: 35210814
[TBL] [Abstract][Full Text] [Related]
10. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
Front Immunol; 2020; 11():1281. PubMed ID: 32765489
[No Abstract] [Full Text] [Related]
11. Polo-like kinase 1 suppresses lung adenocarcinoma immunity through necroptosis.
Zhang P; Zhang X; Zhu Y; Cui Y; Xu J; Zhang W
Oncol Res; 2023; 31(6):937-953. PubMed ID: 37744268
[TBL] [Abstract][Full Text] [Related]
12. PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.
Higuchi F; Fink AL; Kiyokawa J; Miller JJ; Koerner MVA; Cahill DP; Wakimoto H
Mol Cancer Ther; 2018 Dec; 17(12):2551-2563. PubMed ID: 30217967
[TBL] [Abstract][Full Text] [Related]
13. CDYL knockdown reduces glioma development through an antitumor immune response in the tumor microenvironment.
Kong JG; Mei Z; Zhang Y; Xu LZ; Zhang J; Wang Y
Cancer Lett; 2023 Jul; 567():216265. PubMed ID: 37302564
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
[TBL] [Abstract][Full Text] [Related]
15. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma.
Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J
Exp Cell Res; 2024 May; 439(1):114076. PubMed ID: 38719174
[TBL] [Abstract][Full Text] [Related]
16. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
17. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
[TBL] [Abstract][Full Text] [Related]
18. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
[TBL] [Abstract][Full Text] [Related]
19. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma.
Yalcin F; Haneke H; Efe IE; Kuhrt LD; Motta E; Nickl B; Flüh C; Synowitz M; Dzaye O; Bader M; Kettenmann H
Acta Neuropathol Commun; 2024 Apr; 12(1):50. PubMed ID: 38566120
[TBL] [Abstract][Full Text] [Related]
20. Matrix Remodeling-Associated Protein 8 as a Novel Indicator Contributing to Glioma Immune Response by Regulating Ferroptosis.
Xu Z; Chen X; Song L; Yuan F; Yan Y
Front Immunol; 2022; 13():834595. PubMed ID: 35281049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
